DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Sarrazin C, Cooper CL, Manns MP. et al.
No impact of resistance-associated substitutions on the efficacy of sofosbuvir, velpatasvir, and voxilaprevir for 12 weeks in HCV DAA-experienced patients.

Journal of hepatology 2018;
69: 1221-1230

Download Bibliographical Data

Access:
Access: